{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:44:12Z","timestamp":1793983452280,"version":"4.8.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ahj.2015.01.011","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T13:55:21Z","timestamp":1423749321000},"page":"605-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration"],"prefix":"10.1016","volume":"169","author":[{"given":"Alex","family":"Pitcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Emberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald V.","family":"Lacro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A.","family":"Sleeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail D.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Groenink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeilko H.","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"De Paepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloisa","family":"Arbustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guliz","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu Yu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus D.","family":"Flather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Child","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Forteza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hui","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hwan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami B.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Creager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Devereux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Loeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Colin","family":"Forfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Jondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry C.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Baigent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ahj.2015.01.011_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/01.CIR.11.3.321","article-title":"The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue","volume":"11","author":"McKusick","year":"1955","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2015.01.011_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ejechocard\/jen311","article-title":"The expanding cardiovascular phenotype of Marfan syndrome","volume":"10","author":"De Backer","year":"2009","journal-title":"Eur J Echocardiogr"},{"issue":"6","key":"10.1016\/j.ahj.2015.01.011_bb0015","first-page":"335","article-title":"Cardiovascular characteristics in Marfan syndrome and their relation to the genotype","volume":"71","author":"De Backer","year":"2009","journal-title":"Verh K Acad Geneeskd Belg"},{"issue":"6","key":"10.1016\/j.ahj.2015.01.011_bb0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12265-011-9314-y","article-title":"Mitral valve disease in Marfan syndrome and related disorders","volume":"4","author":"Judge","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"issue":"10","key":"10.1016\/j.ahj.2015.01.011_bb0025","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/eurjhf\/hfq127","article-title":"Evidence for Marfan cardiomyopathy","volume":"12","author":"Alpendurada","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"10.1016\/j.ahj.2015.01.011_bb0030","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJM197204132861502","article-title":"Life expectancy and causes of death in the Marfan syndrome","volume":"286","author":"Murdoch","year":"1972","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2015.01.011_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mayocp.2013.08.022","article-title":"Epidemiological profile of Marfan syndrome in a general population: a national database study","volume":"89","author":"Chiu","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1016\/j.ahj.2015.01.011_bb0040","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2010.42","article-title":"Clinical utility gene card for: Marfan syndrome type 1 and related phenotypes [FBN1]","volume":"18","author":"Arslan-Kirchner","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"21","key":"10.1016\/j.ahj.2015.01.011_bb0045","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1161\/CIRCULATIONAHA.107.693523","article-title":"Medical management of Marfan syndrome","volume":"117","author":"Keane","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2015.01.011_bb0050","first-page":"123","article-title":"A prospectus on the prevention of aortic rupture in the Marfan syndrome with data on survivorship without treatment","volume":"129","author":"Halpern","year":"1971","journal-title":"Johns Hopkins Med J"},{"issue":"19","key":"10.1016\/j.ahj.2015.01.011_bb0055","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.ahj.2015.01.011_bb0060","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ahj.2015.01.011_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.108.841981","article-title":"Circulating transforming growth factor-beta in Marfan syndrome","volume":"120","author":"Matt","year":"2009","journal-title":"Circulation"},{"issue":"7347","key":"10.1016\/j.ahj.2015.01.011_bb0070","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nature10145","article-title":"Lessons on the pathogenesis of aneurysm from heritable conditions","volume":"473","author":"Lindsay","year":"2011","journal-title":"Nature"},{"issue":"6333","key":"10.1016\/j.ahj.2015.01.011_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ahj.2015.01.011_bb0080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/humu.21525","article-title":"Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes","volume":"32","author":"Baetens","year":"2011","journal-title":"Hum Mutat"},{"issue":"5770","key":"10.1016\/j.ahj.2015.01.011_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ahj.2015.01.011_bb0090","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","article-title":"Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome","volume":"154","author":"Lacro","year":"2007","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2015.01.011_bb0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.echo.2013.02.018","article-title":"Echocardiographic methods, quality review, and measurement accuracy in a randomized multicenter clinical trial of Marfan syndrome","volume":"26","author":"Selamet Tierney","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"10.1016\/j.ahj.2015.01.011_bb0100","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ahj.2013.02.019","article-title":"Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy","volume":"165","author":"Lacro","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2015.01.011_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-14-408","article-title":"A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol","volume":"14","author":"Mullen","year":"2013","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.ahj.2015.01.011_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acvd.2010.04.008","article-title":"Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome","volume":"103","author":"Detaint","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"issue":"45","key":"10.1016\/j.ahj.2015.01.011_bb0115","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ahj.2015.01.011_bb0120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.recesp.2011.02.009","article-title":"Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome","volume":"64","author":"Forteza","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ahj.2015.01.011_bb0125","first-page":"354","article-title":"The Ghent Marfan Trial\u2014a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with beta-blockers","volume":"14","author":"Moberg","year":"2011","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2015.01.011_bb0130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2459\/JCM.0b013e3283232a45","article-title":"Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations","volume":"10","author":"Gambarin","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"3","key":"10.1016\/j.ahj.2015.01.011_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ahj.2015.01.011_bb0140","author":"Boston Trial"},{"key":"10.1016\/j.ahj.2015.01.011_bb0145","author":"Sandor"},{"issue":"3","key":"10.1016\/j.ahj.2015.01.011_bb0150","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/heartjnl-2013-304946","article-title":"Retrospective analysis of the effect of angiotensin II receptor blocker versus beta-blocker on aortic root growth in paediatric patients with Marfan syndrome","volume":"100","author":"Mueller","year":"2014","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.ahj.2015.01.011_bb0155","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2013.06.019","article-title":"Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome","volume":"112","author":"Pees","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2015.01.011_bb0160","series-title":"Evidence based cardiology","article-title":"Clinical trials and meta-analysis","author":"Emberson","year":"2010"},{"issue":"4","key":"10.1016\/j.ahj.2015.01.011_bb0165","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","article-title":"Revised diagnostic criteria for the Marfan syndrome","volume":"62","author":"De Paepe","year":"1996","journal-title":"Am J Med Genet"},{"issue":"7","key":"10.1016\/j.ahj.2015.01.011_bb0170","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"issue":"9894","key":"10.1016\/j.ahj.2015.01.011_bb0175","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2013","journal-title":"Lancet"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315001015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870315001015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:53:39Z","timestamp":1757570019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870315001015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0002870315001015"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2015.01.011","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2015.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}